Skip to content
10-K/A

Annual Report

CHINA BCT PHARMACY GROUP, INC.

0001213900-12-003270

← back to feed
Filed
Jun 12, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Mar 29, 2012 38.15M sh
Shares Diluted FY 2011 · Dec 31, 2011 38.16M sh
Shares Diluted FY 2011 · Dec 31, 2010 38.42M sh
Capex FY 2011 · Dec 31, 2011 $4.07M
Capex FY 2011 · Dec 31, 2010 $450.11K
Operating Cash Flow restated FY 2011 · Dec 31, 2011 −$5.78M
Operating Cash Flow FY 2011 · Dec 31, 2010 $15.89M
Cash And Equivalents FY 2011 · Dec 31, 2011 $31.48M
Cash And Equivalents FY 2011 · Dec 31, 2010 $20.16M
Cash And Equivalents FY 2011 · Dec 31, 2009 $13.3M
Current Liabilities FY 2011 · Dec 31, 2011 $62.1M
Current Liabilities FY 2011 · Dec 31, 2010 $55.01M
Total Liabilities FY 2011 · Dec 31, 2011 $62.68M
Total Liabilities FY 2011 · Dec 31, 2010 $58.44M
Current Assets FY 2011 · Dec 31, 2011 $172.09M
Current Assets FY 2011 · Dec 31, 2010 $108.26M
Total Assets FY 2011 · Dec 31, 2011 $212.58M
Total Assets FY 2011 · Dec 31, 2010 $141.54M
Sga Expense FY 2011 · Dec 31, 2011 $12.41M
Sga Expense FY 2011 · Dec 31, 2010 $8.1M
Operating Income FY 2011 · Dec 31, 2011 $42.2M
Operating Income FY 2011 · Dec 31, 2010 $35.38M
Gross Profit FY 2011 · Dec 31, 2011 $61.82M
Gross Profit FY 2011 · Dec 31, 2010 $48.82M
Cost Of Revenue FY 2011 · Dec 31, 2011 $195.67M
Cost Of Revenue FY 2011 · Dec 31, 2010 $151.99M
Revenue FY 2011 · Dec 31, 2011 $257.49M
Revenue FY 2011 · Dec 31, 2010 $200.81M